Nipro Diagnostics, a Fort Lauderdale, Fla.-based maker of blood glucose monitoring products, has named Dean Sorrentino CFO. Most recently, Sorrentino was VP Corporate Controller at CompuPay, a private equity-backed provider of payroll and benefit solutions.
Nipro Diagnostics, Inc., a leading manufacturer and marketer of blood glucose monitoring products and supplies for diabetes management, today announced Dean Sorrentino has joined Nipro Diagnostics, Inc. as Chief Financial Officer.
Sorrentino is an executive with more than 15 years of finance experience in both public and private companies. Most recently, he was Vice President Corporate Controller at CompuPay Inc., a private equity backed national provider of payroll and benefit solutions. In May 2012, Sorrentino assisted with the positioning of the company to be acquired and merged with a Texas based company. From January 2006 to April 2009, Sorrentino served as Corporate Controller for Home Diagnostics, Inc., which Nipro Corporation acquired in March 2010. During his tenure at Home Diagnostics, he played an integral role in completing Home Diagnostics’ Initial Public Offering, as well as building the structure and foundation to operate it as a publicly traded healthcare company. Sorrentino also spent more than five years in public accounting with Deloitte & Touche LLP.
Sorrentino will have responsibility for the company’s accounting, treasury, tax, legal and information technology functions, and will partner with other senior executives to oversee companywide business operations.
“I am pleased to have Dean join the Nipro Diagnostics team. He is uniquely suited for this position, as he brings extensive financial knowledge as well as a deep understanding of our business,” said Scott Verner, President and CEO, Nipro Diagnostics.
Added Sorrentino, “Nipro Diagnostics is clearly positioned for continued growth and expansion. I’m excited for this opportunity to bring value and look forward to leveraging my significant healthcare and industry experience.”
Sorrentino holds a Master’s Degree in Accounting from Florida International University and a Bachelor’s Degree in Accounting from the University of Florida. He is a certified public accountant.
About Nipro Diagnostics, Inc.
Based in Fort Lauderdale, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes management products. The company offers a portfolio of high quality blood glucose monitoring systems and products available around the world. Nipro Diagnostics is the exclusive supplier of blood glucose monitoring systems, co-branded under the TRUE name, for leading pharmacies including CVS, Rite Aid, Walgreens and Wegmans; as well as for distributors such as AmerisourceBergen, Cardinal Health, McKesson, Invacare and Liberty Medical. For more information, please visit www.niprodiagnostics.com .
SOURCE: Nipro Diagnostics, Inc.